ABTIOTCdelisted

ALTEROLA BIOTECH INC.

Healthcare·Healthcare·Birkenhead, United Kingdom·CEO: Mr. David John Hitchcock O.B.E.
1.4/10

BioSniper Score

Based on 3 of 6 signals

Limited data coverage

Market Cap

$7.4M

Cash Runway

1.4 mo

Lead Asset

Molecules with patents pending

Next Catalyst

—

Tracking 1 pipeline candidate for ALTEROLA BIOTECH INC. · Updated within the last hour.

Go deeper with Spotter — live AI multi-agent analysis of ALTEROLA BIOTECH INC.

Score breakdownBased on 3 of 6 signals · derived from public data

Cash Runway0.4

1.4 months

Financial Health0.5

OCF -$861K · Net income -$799K

Pipeline MaturityN/A

No tracked pipeline phase

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Unlock the full ALTEROLA BIOTECH INC. dossier

Sign in free to see catalysts, full pipeline, financials, FDA decisions, news, and run live AI deep-dives.

Sign in to unlock

Go deeper on ALTEROLA BIOTECH INC. with Spotter

Ask follow-up questions and run a full multi-agent deep dive on ABTI — live, with citations.

Ask Spotter

Frequently asked questions

Who is the CEO of ALTEROLA BIOTECH INC.?

Mr. David John Hitchcock O.B.E. is the chief executive officer of ALTEROLA BIOTECH INC. (ABTI).

Where is ALTEROLA BIOTECH INC. headquartered?

ALTEROLA BIOTECH INC. (ABTI) is headquartered in Birkenhead, United Kingdom.

909 companies229,531 SEC filings18,827 clinical trials99.99% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.

Get the full picture on ALTEROLA BIOTECH INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free AnalysisBrowse Calendar